Last Updated:
Name Designation Appointment Date Status
Ganesan Subramanian Iyer

Appointed as Director since January 2010

Director 14-Jan-2010 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Rajesh Felix Dsilva

Appointed as Director since January 2010

Director 14-Jan-2010 Current

People Timeline

Explore the timeline of key personnel in Brunhild Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address L4/G3, Royal Complex, Opp. Don Bosco School, Near Laxmi Pink City, Juichandra,, Naigaon Maharashtra, 401102, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 401102
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Brunhild Pharmaceuticals Private Limited?
You can contact Brunhild Pharmaceuticals Private Limited through their registered address at L4/G3, Royal Complex, Opp. Don Bosco School, Near Laxmi Pink City, Juichandra,, Naigaon Maharashtra, 401102, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Brunhild Pharmaceuticals Private Limited?
The current directors of Brunhild Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • GANESAN SUBRAMANIAN IYER
  • RAJESH FELIX DSILVA
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available